Marina Motta

2.2k total citations
25 papers, 264 citations indexed

About

Marina Motta is a scholar working on Genetics, Immunology and Hematology. According to data from OpenAlex, Marina Motta has authored 25 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 9 papers in Immunology and 7 papers in Hematology. Recurrent topics in Marina Motta's work include Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (6 papers) and Immune Cell Function and Interaction (5 papers). Marina Motta is often cited by papers focused on Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (6 papers) and Immune Cell Function and Interaction (5 papers). Marina Motta collaborates with scholars based in Italy, United States and Switzerland. Marina Motta's co-authors include Thomas J. Kipps, Susan Lerner, Michael J. Keating, William G. Wierda, Laura Z. Rassenti, Dennis A. Carson, Christina Wu, Januario E. Castro, Agostino Cortelezzi and Alessandra Ferrajoli and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Marina Motta

23 papers receiving 263 citations

Peers

Countries citing papers authored by Marina Motta

Since Specialization

Citations

This map shows the geographic impact of Marina Motta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Motta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Motta more than expected).

Fields of papers citing papers by Marina Motta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Motta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Motta. The network helps show where Marina Motta may publish in the future.

Co-authorship network of co-authors of Marina Motta

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Motta. A scholar is included among the top collaborators of Marina Motta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Motta. Marina Motta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Semantic meaning means a lot: Exploring the role of semantics in the development of a Big Five taxonomy 2025 ·Journal of Research in Personality ·(unknown), (unknown), Marina Motta, Paulo Mattos, Ronald Fischer	0
2	S147: EFFICACY AND SAFETY RESULTS OF MOLTO, A MULTICENTER, OPEN LABEL, PHASE II CLINICAL TRIAL EVALUATING VENETOCLAX, ATEZOLIZUMAB AND OBINUTUZUMAB COMBINATION IN RICHTER SYNDROME 2023 ·HemaSphere ·Anna Maria Frustaci, Marco Montillo, Davide Rossi, Pier Luigi Zinzani, Marina Motta, Gianluca Gaïdano, Giulia Quaresmini, Lydia Scarfò, Daniela Pietrasanta, Marta Coscia, Marina Deodato, (unknown), Roberto Cairoli, Georg Stüssi, Emanuele Zucca, Stefano Pileri, Thorsten Zenz, Alessandra Tedeschi	1
3	EFFICACY AND SAFETY OF MOLTO, A MULTICENTER, OPEN LABEL, PHASE II CLINICAL TRIAL EVALUATING VENETOCLAX, ATEZOLIZUMAB AND OBINUTUZUMAB COMBINATION IN RICHTER SYNDROME 2023 ·Hematological Oncology ·Anna Maria Frustaci, Marco Montillo, Davide Rossi, Pier Luigi Zinzani, Marina Motta, Gianluca Gaïdano, Giulia Quaresmini, Lydia Scarfò, Daniela Pietrasanta, (unknown), Marina Deodato, (unknown), Roberto Cairoli, Georg Stüssi, Emanuele Zucca, Stefano Pileri, Thorsten Zenz, Alessandra Tedeschi	2
4	Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88 2020 ·Blood ·Antonio Sacco, Cinzia Federico, Arianna Giacomini, (unknown), Federica Maccarinelli, Katia Todoerti, (unknown), Antonella Anastasia, Marina Motta, Domenico Russo, Giuseppe Rossi, (unknown), Riccardo Castelli, Antonino Neri, Roberto Ronca, Chiara Cattaneo, Alessandra Tucci, Marco Mor, Marco Presta, Aldo M. Roccaro	6
5	The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions 2017 ·Oncotarget ·Antonio Sacco, (unknown), (unknown), (unknown), Domenico Russo, Marco Presta, Michele Malagola, Antonella Anastasia, Marina Motta, Christopher J. Patterson, Giuseppe Rossi, Luisa Imberti, Steven P. Treon, Irene M. Ghobrial, Aldo M. Roccaro	4
6	A MRD‐GUIDED APPROACH FOR THE COMBINATION OF IBRUTINIB TO VENETOCLAX IN RELAPSED/REFRACTORY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (IMPROVE STUDY) 2017 ·Hematological Oncology ·Paolo Ghia, Lydia Scarfò, Marta Coscia, R Sancetta, Andrea Ferrario, Alessandra Tedeschi, Lucia Farina, Luca Laurenti, Ester Orlandi, Gianluigi Reda, Marina Motta, Carmelo Carlo‐Stella, Massimo Massaia, Giulia Quaresmini, Fausto Rossini, Marco Ladetto, Gianluca Gaïdano, Antônio Rossi, Marco Montillo	0
7	Abstract P4-22-12: Ribociclib + fulvestrant in postmenopausal women with HR+, HER2– advanced breast cancer (ABC) 2017 ·Cancer Research ·SM Tolaney, (unknown), Valentina Boni, Thomas Bachelot, Yen‐Shen Lu, (unknown), Angelica Fasolo, Marina Motta, (unknown), Jason R. Dobson, Becker Hewes, (unknown)	4
8	500 Triple blockade with LEE011, everolimus, and exemestane in women with ER+/HER2− advanced/metastatic breast cancer: results from a Phase Ib clinical trial 2014 ·European Journal of Cancer ·Aditya Bardia, (unknown), Shanu Modi, Mario Campone, Brigette Ma, Muaiad Kittaneh, Luc Dirix, Marina Motta, (unknown), Suraj G. Bhansali, (unknown), Mafalda Oliveira	4
9	Fludarabine, Cyclophosphamide, and Rituximab in Salvage Therapy of Waldenström's Macroglobulinemia 2013 ·Clinical Lymphoma Myeloma & Leukemia ·Alessandra Tedeschi, Francesca Ricci, Maria Goldaniga, Giulia Benevolo, Marzia Varettoni, Marina Motta, Pietro Pioltelli, Guido Gini, Claudia Baratè, (unknown), (unknown), Anna Maria Frustaci, Michele Nichelatti, Umberto Vitolo, Luca Baldini, Enrica Morra	18
10	A Phase II Multi-Center Trial Of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) In Older Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients 2013 ·Blood ·Marco Montillo, Davide Rossi, Marina Motta, Giulia Quaresmini, Marianna Rossi, Marta Coscia, Antonella Anastasia, Fausto Rossini, Agostino Cortelezzi, (unknown), Lydia Scarfò, Roberto Cairoli, (unknown), Lorenzo De Paoli, Enrica Morra, Alessandro Rambaldi, Ester Orlandi, Massimo Massaia, Alessandra Tedeschi	5
11	Quantification of newly produced B and T lymphocytes in untreated chronic lymphocytic leukemia patients 2010 ·Journal of Translational Medicine ·Marina Motta, Marco Chiarini, Claudia Ghidini, Cinzia Zanotti, (unknown), Luigi Caimi, Giuseppe Rossi, Luisa Imberti	19
12	Chronic lymphocytic leukemia 2009 ·Cancer ·Marina Motta, William G. Wierda, Alessandra Ferrajoli	10
13	Thymidine-phosphorothioate oligonucleotides induce activation and apoptosis of CLL cells independently of CpG motifs or BCL-2 gene interference 2006 ·Leukemia ·Januario E. Castro, Carlos E. Prada, (unknown), Shinichi Kitada, Tetsuya Fukuda, Marina Motta, Christina Wu, Frank Dicker, Guizhen Sun, J Y J Wang, Dennis A. Carson, John C. Reed, Thomas J. Kipps	20
14	Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia 2005 ·Leukemia ·Marina Motta, Laura Z. Rassenti, (unknown), Susan Lerner, Thomas J. Kipps, Michael J. Keating, William G. Wierda	90
15	Infections in Patients with Chronic Lymphocytic Leukemia Treated with Chemoimmunotherapy. 2005 ·Blood ·Marina Motta, William G. Wierda, Susan O’Brien, Stefan Faderl, Alessandra Ferrajoli, Michelle A. Detry, Susan Lerner, Hagop M. Kantarjian, Michael J. Keating	2
16	Increased Expression of CD152 by Normal T Lymphocytes in Untreated Patients with B Cell Chronic Lymphocytic Leukemia. 2004 ·Blood ·Marina Motta, (unknown), Susan Lerner, Michael J. Keating, William G. Wierda	3
17	Selection of Oligonucleotide Aptamers with Enhanced Uptake and Activation of Human Leukemia B Cells 2003 ·Human Gene Therapy ·Christina Wu, Januario E. Castro, Marina Motta, Howard B. Cottam, Diego Kyburz, Thomas J. Kipps, Maripat Corr, Dennis A. Carson	27
18	Biological and molecular characterization of PNH‐like lymphocytes emerging after Campath‐1H therapy 2001 ·British Journal of Haematology ·Nicola Stefano Fracchiolla, Wilma Barcellini, Paola Bianchi, Marina Motta, Elisa Fermo, Agostino Cortelezzi	11
19	Hyperhomocysteinemia in Myelodysplastic Syndromes: Specific Association with Autoimmunity and Cardiovascular Disease 2001 ·Leukemia & lymphoma ·Agostino Cortelezzi, Nicola Stefano Fracchiolla, (unknown), Marina Motta, Giuliana Cighetti, M Carrabba, Viviana Cavalca, (unknown), Giorgio La Nasa	8
20	Efficacy of N-acetylcysteine and all-trans retinoic acid in restoring in vitro effective hemopoiesis in myelodysplastic syndromes 2000 ·Leukemia Research ·Agostino Cortelezzi, Chiara Cattaneo, Barbara Sarina, (unknown), Mauro Pomati, Ilaria Silvestris, Marina Motta, Adalberto Ibatici, (unknown), Aldo Della Volpe, Anna Teresa Maiolo	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact